Company

Our
Company

We are more than a radioisotope supplier. We are solving the challenges facing U.S. radioisotope customers and constantly evolving to meet changing needs.

IN OUR EFFORTS TO DELIVER
CREATIVE SOLUTIONS, WE
CLEARLY DEFINE

WHO
WE ARE

We are innovators who revolutionized the reliable production of Mo-99. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics and therapeutics that will serve the next generation of medical advances for patients.

THE RADIOPHARMACEUTICAL MARKET
DEMANDS CREATIVE, ORIGINAL
THINKING, LIKE THAT PIONEERED BY OUR

LEADERSHIP
TEAM

Our executive team brings proven experience and expertise in developing and commercializing innovative nuclear medicine products and technologies.

LATEST NEWS, PRESS RELEASES & EVENTS


Press Releases - Jul 19, 2022
NorthStar Medical Radioisotopes Announces Supply Agreement with Clovis Oncology for Therapeutic Radioisotope Actinium-225 (Ac-225)

News - Jul 15, 2022
UWM grads help provide domestic source of critical medical diagnostic material

Press Releases - Jun 20, 2022
NorthStar Medical Technologies, LLC Announces Promotion of Frank Scholz, Ph.D., to President and Chief Operating Officer
Oct 5, 2022 - Oct 7, 2022
Meeting
U.S. Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) 2022 Mo-99 International Symposium
Speaking, Sponsoring, Attending